日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

瑞士一项针对类风湿性关节炎患者的观察性队列研究比较了抗肿瘤坏死因子药物、作用机制不同的生物制剂和托法替尼的疗效

Finckh, A; Tellenbach, C; Herzog, L; Scherer, A; Moeller, B; Ciurea, A; von Muehlenen, I; Gabay, C; Kyburz, D; Brulhart, L; Müller, R; Hasler, P; Zufferey, P

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

对于既往使用抗肿瘤坏死因子 (TNF) 药物治疗失败的类风湿性关节炎患者,改用利妥昔单抗而非其他抗肿瘤坏死因子 (TNF) 药物能获益的亚组患者有哪些?

Finckh, A; Ciurea, A; Brulhart, L; Möller, B; Walker, U A; Courvoisier, D; Kyburz, D; Dudler, J; Gabay, C

Cigarette smoking and radiographic progression in rheumatoid arthritis

吸烟与类风湿性关节炎的放射学进展

Finckh, A; Dehler, S; Costenbader, K H; Gabay, C

Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis

类风湿性关节炎中抗肿瘤坏死因子药物获得性耐药性差异的证据

Finckh, A; Simard, J F; Gabay, C; Guerne, P-A

Rituximab in the treatment of antisynthetase syndrome

利妥昔单抗治疗抗合成酶综合征

Brulhart, L; Waldburger, J-M; Gabay, C

Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study

B细胞清除疗法对难治性类风湿性关节炎患者的疗效:一项开放标签观察性研究

Brulhart, L; Ciurea, A; Finckh, A; Notter, A; Waldburger, J M; Kyburz, D; Gabay, C

Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint

胶原诱导性关节炎的缓解与关节中转化生长因子-β的高表达水平相关。

Marinova-Mutafchieva, L; Gabay, C; Funa, K; Williams, R O

Etanercept in treatment of Felty's syndrome

依那西普治疗费尔蒂综合征

Ghavami, A; Genevay, S; Fulpius, T; Gabay, C

Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study

依那西普治疗急性重度坐骨神经痛的疗效:一项初步研究

Genevay, S; Stingelin, S; Gabay, C

Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts.

干扰素β刺激人类关节软骨细胞和滑膜成纤维细胞产生白细胞介素1受体拮抗剂

Palmer G, Mezin F, Juge-Aubry C E, Plater-Zyberk C, Gabay C, Guerne P-A